【RAND Corporation】【2025】Assessing Cumulative, Meaningful Benefits of Disease-Modifying Therapies Targeting Synucleinopathies-32页

RAND Corporation 卫生和社会工作 2025年 PDF 1.96 MB

disease-modifying therapies dementia with Lewy bodies Parkinson's disease synucleinopathies multiple system atrophy